pharma · Advanced Refractory Solid Tumors
CStone Pharmaceuticals
Cstone Pharmaceuticals Ireland Limited
Cstone Pharmaceuticals Ireland is a pharma organization headquartered in GB. Primary therapeutic focus areas include Advanced Refractory Solid Tumors. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0
Shanghai, CN HQ
2016 Founded
193 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Shanghai, CN
- Founded
- 2016
- Employees
- 193
- Programs
- 1
- Drugs
- 1
- Patents
- 0
CS1001
Phase 2 · small molecule · Advanced Refractory Solid Tumors
CS1001 for Advanced Refractory Solid Tumors is a Phase 2 program (small_molecule) at Cstone Pharmaceuticals Ireland Limited with 1 ClinicalTrials.gov record(s).
Internal code CS1001/Regorafenib-101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Cstone Pharmaceuticals Ireland Limited
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Advanced Refractory Solid Tumors
- Status
- completed
- Trials
- 1